Overview
Kansas City Heart Rhythm Symposium 2019
Registration is closed for this activity.
The purpose of this symposium is to update medical practitioners in the greater Midwest region on the future of cardiac electrophysiology (EP), and on new diagnosis and treatment guidelines in the care and management of patients with arrhythmias, heart failure and other issues impacting the electrical system of the body. Participants will learn about advances in ablation techniques, device management, appropriate use criteria, and survey new developments in guidelines and recommendations. A review of clinical trials that have helped change the clinical practice of EP will also be held. Participants in this symposium will examine the latest trends in Left Atrial Appendage (LAA) treatment options and gain a greater understanding of anticoagulation and stroke prophylaxis.
Full refunds will only be given prior to August 1, 2019. Registration cancellation refunds will not be made after August 1 at 11:59 PM Central Time, and cancellations after this time will have a $30 administrative processing fee applied to the card on file.
Please note, Kansas University pre registrants may encounter difficulties when registering since a firewall prevents registration. In this case, please utilize a personal home computer.
Full refunds will only be given prior to August 1, 2019. Registration cancellation refunds will not be made after August 1 at 11:59 PM Central Time, and cancellations after this time will have a $30 administrative processing fee applied to the card on file.
Please note, Kansas University pre registrants may encounter difficulties when registering since a firewall prevents registration. In this case, please utilize a personal home computer.
This symposium is designed for physicians, advanced practice registered nurses, nurses and allied health professionals in the fields of electrophysiology, interventional cardiology, interventional radiology, and vascular surgery.
The purpose of this symposium is to update medical practitioners in the greater Midwest region on the future of cardiac electrophysiology (EP), and on new diagnosis and treatment guidelines in the care and management of patients with arrhythmias, heart failure and other issues impacting the electrical system of the body. Participants will learn about advances in ablation techniques, device management, appropriate use criteria, and survey new developments in guidelines and recommendations. A review of clinical trials that have helped change the clinical practice of EP will also be held. Participants in this symposium will examine the latest trends in Left Atrial Appendage (LAA) treatment options and gain a greater understanding of anticoagulation and stroke prophylaxis.
The program will address the following learning objectives:
- Discuss types of devices used for monitoring and treatment of arrhythmias
- Describe alternative therapies of treatment in patients with arrhythmias
- Review guidelines for arrhythmia therapies
- Discuss advances in ablative techniques for arrhythmias
- Demonstrate the use of imaging techniques to improve procedural outcomes
- Apply guideline-endorsed, clinically applicable strategies to help resolve lead failure, device malfunctions, and other device-related issues
- Discuss how to improve safety and efficacy of electrophysiology (EP) procedures
- Summarize clinical trials that helped change clinical practice in the EP field
- Identify updates in heart failure treatment options
- Investigate the role that genetics has in patients with arrhythmias
- Explain anticoagulation treatment and stroke prophylaxis options for cardiac patients
- Examine clinical evidence for the latest trends in LAA treatments
Sheraton Overland Park Hotel and the Convention Center
6100 College Boulevard
Overland Park, KS 66211 USA
Click here to view location map
Phone: (913) 234-2100
6100 College Boulevard
Overland Park, KS 66211 USA
Click here to view location map
Phone: (913) 234-2100
For additional details, please visit the conference website at www.kchrs.com.
The content for this activity was developed independently. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and KCHRS Foundation. ACHL is accredited by the ACCME to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this live activity for a maximum of 11.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Provider approved by the California Board of Registered Nursing, Provider Number CEP17273 for 11.75 contact hours.
The Academy for Continued Healthcare Learning designates this live activity for a maximum of 11.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Provider approved by the California Board of Registered Nursing, Provider Number CEP17273 for 11.75 contact hours.
